On the other hand, clinical trials of IGF-1 in children with Rett syndrome and rapamycin in children with TSC have not thus far had promising effects on behavior (Khwaja et al., 2014, Sahin M, 2018b, Sahin M, 2018a). Here, IGF1 is linked to Rett syndrome.